FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3202862364> ?p ?o ?g. }

• W3202862364 endingPage "1452" @default.
• W3202862364 startingPage "1443" @default.
• W3202862364 abstract "Objective The primary objective of the study was to validate the European Society for Medical Oncology (ESMO)–European Society of Gynecologic Oncology (ESGO) ovarian cancer guideline as a method of assessing quality of care, and to identify patient characteristics predictive of non-adherence to European guideline care. The secondary objectives were to analyze the evolution of practices over the years and to evaluate heterogeneity between centers. Methods This retrospective multicenter cohort study of invasive epithelial ovarian cancer reported to the FRANCOGYN database included data from 12 French centers between January 2000 and February 2017. The main outcome was adherence to ESMO–ESGO guidelines, defined by recommended surgical procedures according to the International Federation of Gynecology and Obstetrics (FIGO) stage and appropriate chemotherapy. Mixed multivariable logistic regression analysis with a random center effect was performed to estimate the probability of adherence to the guidelines. Survival analysis was carried out using the Kaplan–Meier method and a mixed Cox proportional hazards model. Results 1463 patients were included in the study. Overall, 317 (30%) patients received complete guideline adherent care. Patients received appropriate surgical treatment in 69% of cases, while adequate chemotherapy was administered to 44% of patients. Both patient demographics and disease characteristics were significantly associated with the likelihood of receiving guideline adherent care, such as age, performance status, FIGO stage, and initial burden of disease. In univariate and multivariate survival analysis, adherence to the guidelines was a statistically significant and independent predictor of decreased overall survival. Patients receiving suboptimal care experienced an increased risk of death of more than 100% compared with those treated according to the guidelines (hazard ratio 2.14, 95% confidence interval 1.32 to 3.47, p<0.01). In both models, a significant random center effect was observed, confirming the heterogeneity between centers (p<0.001). Conclusions Adherence to ESMO–ESGO guidelines in ovarian cancer was associated with a higher overall survival and may be a useful method of assessing quality of care." @default.
• W3202862364 created "2021-10-11" @default.
• W3202862364 creator A5004028254 @default.
• W3202862364 creator A5006716940 @default.
• W3202862364 creator A5011170971 @default.
• W3202862364 creator A5013354457 @default.
• W3202862364 creator A5023324234 @default.
• W3202862364 creator A5026513661 @default.
• W3202862364 creator A5036623498 @default.
• W3202862364 creator A5045904002 @default.
• W3202862364 creator A5051695025 @default.
• W3202862364 creator A5053722774 @default.
• W3202862364 creator A5056462028 @default.
• W3202862364 creator A5058559504 @default.
• W3202862364 creator A5070689648 @default.
• W3202862364 creator A5074845236 @default.
• W3202862364 creator A5075572109 @default.
• W3202862364 creator A5080332706 @default.
• W3202862364 creator A5082896283 @default.
• W3202862364 creator A5082917081 @default.
• W3202862364 creator A5087960987 @default.
• W3202862364 date "2021-10-04" @default.
• W3202862364 modified "2023-10-14" @default.
• W3202862364 title "Adherence to European ovarian cancer guidelines and impact on survival: a French multicenter study (FRANCOGYN)" @default.
• W3202862364 cites W1537880623 @default.
• W3202862364 cites W1998381493 @default.
• W3202862364 cites W2010863952 @default.
• W3202862364 cites W2045030606 @default.
• W3202862364 cites W2047970657 @default.
• W3202862364 cites W2067282323 @default.
• W3202862364 cites W2090678250 @default.
• W3202862364 cites W2100355345 @default.
• W3202862364 cites W2109925286 @default.
• W3202862364 cites W2112029015 @default.
• W3202862364 cites W2124784637 @default.
• W3202862364 cites W2154197196 @default.
• W3202862364 cites W2159668287 @default.
• W3202862364 cites W2313068577 @default.
• W3202862364 cites W2516496845 @default.
• W3202862364 cites W2528353474 @default.
• W3202862364 cites W2897883552 @default.
• W3202862364 cites W2910447973 @default.
• W3202862364 cites W2922316760 @default.
• W3202862364 cites W3008554862 @default.
• W3202862364 cites W3023274953 @default.
• W3202862364 cites W3023360011 @default.
• W3202862364 cites W3048416587 @default.
• W3202862364 cites W3128646645 @default.
• W3202862364 cites W3164882499 @default.
• W3202862364 cites W4247537694 @default.
• W3202862364 doi "https://doi.org/10.1136/ijgc-2021-002934" @default.
• W3202862364 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34607855" @default.
• W3202862364 hasPublicationYear "2021" @default.
• W3202862364 type Work @default.
• W3202862364 sameAs 3202862364 @default.
• W3202862364 citedByCount "7" @default.
• W3202862364 countsByYear W32028623642022 @default.
• W3202862364 countsByYear W32028623642023 @default.
• W3202862364 crossrefType "journal-article" @default.
• W3202862364 hasAuthorship W3202862364A5004028254 @default.
• W3202862364 hasAuthorship W3202862364A5006716940 @default.
• W3202862364 hasAuthorship W3202862364A5011170971 @default.
• W3202862364 hasAuthorship W3202862364A5013354457 @default.
• W3202862364 hasAuthorship W3202862364A5023324234 @default.
• W3202862364 hasAuthorship W3202862364A5026513661 @default.
• W3202862364 hasAuthorship W3202862364A5036623498 @default.
• W3202862364 hasAuthorship W3202862364A5045904002 @default.
• W3202862364 hasAuthorship W3202862364A5051695025 @default.
• W3202862364 hasAuthorship W3202862364A5053722774 @default.
• W3202862364 hasAuthorship W3202862364A5056462028 @default.
• W3202862364 hasAuthorship W3202862364A5058559504 @default.
• W3202862364 hasAuthorship W3202862364A5070689648 @default.
• W3202862364 hasAuthorship W3202862364A5074845236 @default.
• W3202862364 hasAuthorship W3202862364A5075572109 @default.
• W3202862364 hasAuthorship W3202862364A5080332706 @default.
• W3202862364 hasAuthorship W3202862364A5082896283 @default.
• W3202862364 hasAuthorship W3202862364A5082917081 @default.
• W3202862364 hasAuthorship W3202862364A5087960987 @default.
• W3202862364 hasConcept C121608353 @default.
• W3202862364 hasConcept C126322002 @default.
• W3202862364 hasConcept C142724271 @default.
• W3202862364 hasConcept C143998085 @default.
• W3202862364 hasConcept C144301174 @default.
• W3202862364 hasConcept C146357865 @default.
• W3202862364 hasConcept C151730666 @default.
• W3202862364 hasConcept C151956035 @default.
• W3202862364 hasConcept C167135981 @default.
• W3202862364 hasConcept C2780182762 @default.
• W3202862364 hasConcept C2780427987 @default.
• W3202862364 hasConcept C2780435969 @default.
• W3202862364 hasConcept C38180746 @default.
• W3202862364 hasConcept C50382708 @default.
• W3202862364 hasConcept C71924100 @default.
• W3202862364 hasConcept C72563966 @default.
• W3202862364 hasConcept C86803240 @default.
• W3202862364 hasConceptScore W3202862364C121608353 @default.
• W3202862364 hasConceptScore W3202862364C126322002 @default.
• W3202862364 hasConceptScore W3202862364C142724271 @default.

• next